Literature DB >> 8562436

Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds.

J M Griscavage1, A J Hobbs, L J Ignarro.   

Abstract

These observations clearly indicate that NO inhibits NOS activity and that nNOS and eNOS are more sensitive than iNOS to the inhibitory action of NO. Not only exogenously added NO but also enzymatically generated NO inhibits the activity of nNOS and eNOS. The mechanism by which NO inhibits NOS appears to involve the heme iron prosthetic group of NOS. Moreover, the oxidation state of the heme iron is critical in determining the magnitude of inhibition of NOS by NO. Conditions that favor the higher oxidation state of FeIII markedly increase the inhibitory action of NO, whereas conditions that favor the lower oxidation state of FeII markedly decrease the inhibitory action of NO. One of the cofactor roles of tetrahydrobiopterin may be to reduce the negative-feedback effect of NO on NOS by favoring the formation of the ferrous heme state in NOS. The inhibitory influence of NO on eNOS, albeit indirectly, was also observed in vascular endothelial cells, arterial rings, and in vivo in the perfused rabbit hindquarters vascular bed. Excess NO in the form of NO donor compounds inhibited the endothelium-dependent formation of EDRF/NO in response to endothelium-dependent vasorelaxants such as acetylcholine and bradykinin without influencing the relaxant effect of NO itself. These studies are consistent with the view that enzymatically generated NO may play an important negative-feedback regulatory role on eNOS, and therefore on vascular endothelial cell function. Several biological implications of a negative-feedback modulatory effect by NO on constitutive isoforms of NOS are evident. In nonadrenergic-noncholinergic transmission, in which NO is believed to be the principal inhibitory neurotransmitter (Sanders and Ward, 1992; Rand, 1992; Rajfer et al., 1992), NO may regulate its own synthesis, and therefore the neurotransmission process. Excess NO production may be undesirable because of the potential of NO or a reaction product of NO to elicit cytotoxic effects. Many extraneuronal factors could also contribute to decreasing the potentially cytotoxic actions of NO. For example, reduced hemoproteins such as hemoglobin, myoglobin, and/or their oxygen adducts could inactivate NO, as could superoxide anion generated in the vicinity of NO. In vascular endothelial cells either enzymatically generated NO or the presence of exogenously added NO in the form of nitrovasodilator drugs could diminish the vasodilator responses to endothelium-dependent relaxants and flow or shear stress. Although iNOS is less sensitive than either eNOS or nNOS to inhibition by NO, the generation of relatively large quantities of NO by iNOS within the confines of a cell may lead to a negative-feedback effect. The concomitant generation of superoxide anion by the same or adjacent cells could result in a diminished negative-feedback effect because of the rapid reaction between NO and superoxide anion to form peroxynitrite. Thus, NO production would increase and there would be increased peroxynitrite formation as well, which would result in enhanced cytotoxicity, provided that peroxynitrite is a cytotoxic species. Alternatively, iNOS may be conveniently insensitive to NO in order to allow for the generation of large quantities of NO for the purpose of producing cytotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562436     DOI: 10.1016/s1054-3589(08)61088-1

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  21 in total

Review 1.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

2.  Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-01       Impact factor: 3.619

3.  Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride.

Authors:  A O Oyekan; T Youseff; D Fulton; J Quilley; J C McGiff
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma.

Authors:  F L M Ricciardolo; M C Timmers; J K Sont; G Folkerts; P J Sterk
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

5.  S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.

Authors:  A Jakubowski; N Maksimovich; R Olszanecki; A Gebska; H Gasser; B K Podesser; S Hallström; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

Review 6.  Nitric oxide homeostasis as a target for drug additives to cardioplegia.

Authors:  B K Podesser; S Hallström
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

7.  Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis.

Authors:  Koh Kawasaki; Robert S Smith; Chung-Ming Hsieh; Jianxin Sun; Julie Chao; James K Liao
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  Modulation of regional nitric oxide metabolism: blood glucose control or insulin?

Authors:  Björn Ellger; Lies Langouche; Milan Richir; Yves Debaveye; Ilse Vanhorebeek; Tom Teerlink; Paul A Van Leeuwen; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 17.440

Review 9.  Age-related changes in redox signaling and VSMC function.

Authors:  Muyao Li; Naomi K Fukagawa
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

10.  Naphthoquinones and bioactive compounds from tobacco as modulators of neuronal nitric oxide synthase activity.

Authors:  Priya Venkatakrishnan; C Gary Gairola; Neal Castagnoli; R Timothy Miller
Journal:  Phytother Res       Date:  2009-12       Impact factor: 5.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.